Our Team
Introduce the scientific, clinical, and business leaders guiding SWL Therapeutics.
President and Chief Scientific Officer
Dr. Wang is a renal and transplant physiology researcher whose NIH-supported work focuses on blood pressure regulation, renal hemodynamics, kidney injury, and graft dysfunction after transplantation. She brings deep expertise in academic discovery and translational research to SWL Therapeutics.
Chief Executive Officer
Mr. Sun brings a technology and entrepreneurship background to SWL Therapeutics. Before 2020, he worked as a software developer and manager, building experience in product execution, team leadership, and operational problem-solving. In 2020, he founded Sundial Financials LLC and has since developed six years of entrepreneurial experience guiding early-stage business strategy and execution.
On-site Scientist and Advisor
Dr. Liu is a professor of Molecular Pharmacology & Physiology and Director of the USF Health Transplant Research Center. His research focuses on renal physiology, hypertension mechanisms, kidney disease, and solid organ transplantation models, providing SWL Therapeutics with senior scientific guidance in translational renal and transplant research.